These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8893115)

  • 1. Barriers to compliance with OBRA'90 regulations in community pharmacies.
    Barnes JM; Riedlinger JE; McCloskey WW; Montagne M
    Ann Pharmacother; 1996 Oct; 30(10):1101-5. PubMed ID: 8893115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a comprehensive community pharmacy patient intake form compliant with OBRA'90 requirements.
    Borja-Hart NL; Maniscalco-Feichtl M
    J Pharm Pract; 2011 Oct; 24(5):480-4. PubMed ID: 21844217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barriers to providing cognitive services.
    Raisch DW
    Am Pharm; 1993 Dec; NS33(12):54-8. PubMed ID: 8304273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-OBRA '90 Medicaid survey: how community pharmacy practice is changing.
    Pugh CB
    Am Pharm; 1995 Feb; NS35(2):17-23. PubMed ID: 7900647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Provision of drug information to patients by pharmacists: the impact of the Omnibus Budget Reconciliation Act of 1990 a decade later.
    Schatz R; Belloto RJ; White DB; Bachmann K
    Am J Ther; 2003; 10(2):93-103. PubMed ID: 12629587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient counseling in community pharmacy and its relationship with prescription payment methods and practice settings.
    Raisch DW
    Ann Pharmacother; 1993 Oct; 27(10):1173-9. PubMed ID: 8251681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inner-city pharmacies: can they meet the OBRA '90 mandates?
    Reutzel TJ; Wilson LA; Mickel M; Lee J; Anderson K; Gray S; Borkowski J; Manasse H; Cooksey J
    Am Pharm; 1993 May; NS33(5):44-51. PubMed ID: 8333408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New York City pharmacists and OBRA '90: one year later.
    Rumore MM; Feifer S; Rumore JS
    Am Pharm; 1995 Feb; NS35(2):29-34, 66. PubMed ID: 7900649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Washington State CARE Project: downstream cost changes associated with the provision of cognitive services by pharmacists.
    Smith DH; Fassett WE; Christensen DB
    J Am Pharm Assoc (Wash); 1999; 39(5):650-7. PubMed ID: 10533346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacist self-reported antidepressant medication counseling.
    Cannon-Breland ML; Westrick SC; Kavookjian J; Berger BA; Shannon DM; Lorenz RA
    J Am Pharm Assoc (2003); 2013; 53(4):390-9. PubMed ID: 23892812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of unmet demand for pharmacists: a survey of rural community pharmacies in Wisconsin.
    Gadkari AS; Mott DA; Kreling DH; Bonnarens JK
    J Am Pharm Assoc (2003); 2008; 48(5):598-609. PubMed ID: 18826899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacy-perceived barriers to cancer pain control: results of the North Carolina Cancer Pain Initiative Pharmacist Survey.
    Krick SE; Lindley CM; Bennett M
    Ann Pharmacother; 1994; 28(7-8):857-62. PubMed ID: 7949500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OBRA '90: the impact on pharmacists and patients.
    Perri M; Kotzan J; Pritchard L; Ozburn W; Francisco G
    Am Pharm; 1995 Feb; NS35(2):24-8, 65. PubMed ID: 7900648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of OBRA '90 on pharmacists' patient counseling practices.
    Scott DM; Wessels MJ
    J Am Pharm Assoc (Wash); 1997; NS37(4):401-6. PubMed ID: 9519650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuing effects of Medicare Part D on rural independent pharmacies who are the sole retail provider in their community.
    Radford A; Mason M; Richardson I; Rutledge S; Poley S; Mueller K; Slifkin R
    Res Social Adm Pharm; 2009 Mar; 5(1):17-30. PubMed ID: 19285286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmaceutical counseling: Between evidence-based medicine and profits.
    Egorova SN; Akhmetova T
    Int J Risk Saf Med; 2015; 27 Suppl 1():S87-8. PubMed ID: 26639727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Migraine management in community pharmacies: practice patterns and knowledge of pharmacy personnel in Thailand.
    Saengcharoen W; Lerkiatbundit S
    Headache; 2013 Oct; 53(9):1451-63. PubMed ID: 23808927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of an over-the-counter intervention follow-up program in community pharmacies.
    Bosse N; Machado M; Mistry A
    J Am Pharm Assoc (2003); 2012; 52(4):535-40, 5 p following 540. PubMed ID: 22825235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient counseling practices in U.S. pharmacies: effects of having pharmacists hand the medication to the patient and state regulations on pharmacist counseling.
    Kimberlin CL; Jamison AN; Linden S; Winterstein AG
    J Am Pharm Assoc (2003); 2011; 51(4):527-34. PubMed ID: 21752776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arkansas community pharmacists' opinions on providing immunizations.
    Pace AC; Flowers SK; Hastings JK
    J Pharm Pract; 2010 Oct; 23(5):496-501. PubMed ID: 21507853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.